Omid Veiseh, professor in the Departments of Bioengineering and Chemical and Biomolecular Engineering in the George R. Brown School of Engineering and Computing at Rice University; a CPRIT Scholar in Cancer Research, and director of Rice Biotechnology Launch Pad, was inducted by the American Institute for Medical and Biological Engineering (AIMBE) into its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions afforded to medical and biological engineers, comprising the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to "engineering and medicine, research, practice, or education” and to "the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education."
Veiseh was nominated, reviewed, and elected by peers and members of the College of Fellows “for advancement of cell-based therapeutics toward developing transformative medicines for treating cancer, metabolic diseases, Type-1 diabetes, and inflammatory disorders.”
"It is truly a great honor to be elected to the AIMBE College of Fellows, who are among the most innovative and esteemed group of biomedical researchers tackling society’s pressing medical challenges,” Veiseh said.
The AIMBE College of Fellows has inducted Fellows representing more than 30 countries who are employed in academia, industry, clinical practice, and government.
AIMBE Fellows are among the most distinguished medical and biological engineers including four Nobel Prize laureates and 27 Presidential Medal of Science and/or Technology and Innovation awardees. Additionally, 233 Fellows have been inducted to the National Academy of Engineering, 120 inducted to the National Academy of Medicine, and 51 inducted to the National Academy of Sciences.
About AIMBE
AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize excellence, advance public understanding, and accelerate medical and biological innovation. No other organization brings together academic, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on Capitol Hill and beyond.